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Conclusions. These data suggest that anemia is associated with reduced QoL in 
patients with HF. Additional studies will be required to establish if this is a cause and 
effect relationship.
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1144-103 Chronic Infusion of Bradykinin Preserves Vascular 
Nitric Oxide-Mediated Endothelial Function and Limits 
the Alteration in Left Ventricular Function During 
Pacing-Induced Heart Failure in Conscious Dogs
Jinbo Su, Daniel Tonduangu, Bijan Ghaleh, Philippe Le Corvoisier, Fanny Vincent, 
Thierry Badoual, Lucien Sambin, Alain Berdeaux, Bertrand Crozatier, Luc Hittinger, 
INSERM, Créteil, France, INSERM, Kremlin-Bicêtre, France
It has been shown that bradykinin (BK) is involved in the beneficial effects of angiotensin-
converting enzyme inhibitors on vascular endothelial and left ventricular (LV) functions in
heart failure (HF). However, it is not known whether BK per se exerts a protective action
on vascular and cardiac functions during the development of HF. This study examined the
effects of chronic BK infusion on cardiac and vascular nitric oxide (NO)-mediated endot-
helial functions during pacing-induced HF in conscious dogs. Sixteen beagle dogs were
chronically instrumented to measure cardiac output, LV pressure, LV wall thickness and
left and right atrial and aortic pressures. After baseline recording and examining the
vasodilator responses to intravenous acetylcholine (ACh, 0.3-3 µg/kg) and nitroglycerin
(NTG, 1-10 µg/kg) in the control state, dogs were randomized to receive through left atria
either water (vehicle group) or BK (1 µg/min, which does not change systemic hemody-
namics; BK group) during right ventricular pacing (250 beats/min, 5 weeks). The vasodi-
lator responses to ACh and NTG were again examined after 3 and 5 weeks of pacing.
The expression of endothelial NO synthase (eNOS) in femoral, carotid and renal arteries
was determined by Western blot analysis. After 3 weeks of pacing, the BK group had a
lesser degree of HF than the vehicle group as indicated by less alterations in LV end-
diastolic pressure (+10±3 vs +19±2 mmHg, p<0.05), LV wall thickening (-33±18 vs -
75±9%, p<0.05) and cardiac output (-16±6 vs -32±6%, p<0.05). Total peripheral resis-
tance (TPR) increased in the vehicle group (+18±10%, p<0.05) but remained unchanged
in the BK group (+1±8%). In both groups during HF, TPR response to NTG was not
altered. In contrast, TPR response to ACh was blunted in the vehicle group (p<0.01) but
was unchanged in the BK group. Similar trends were also observed after 5 weeks of pac-
ing. In all examined arterial beds, eNOS protein expression decreased significantly in the
vehicle group but was preserved in the BK group. Thus, in conscious dogs, chronic BK
infusion limits alterations in LV function and preserves vascular endothelial NO-mediated
vasodilation and thereby delays the progression of HF.
1144-104 The Novel Organic Nitroxyl Donor, Isopropylamine/Nitric 
Oxide Exerts Beta-Independent Positive Inotropy/
Lusitropy in Failing Hearts
Tatsuo Katori, Carlo G. Tocchetti, Katrina M. Miranda, Hunter C. Champion, Jon M. 
Fukuto, David A. Wink, David A. Kass, Nazareno Paolocci, The Johns Hopkins 
University, Baltimore, MD, National Institutes of Health, Bethesda, MD
BackGround: The Nitroxyl (HNO/NO-) donor Angeli’s salt (AS) is a potent inotropic/lusi-
tropic agent both in healthy and heart failure dogs. Its action linked in part to activation of
non-adrenergic/non-cholinergic (NANC) fibers to release calcitonin gene-related peptide
(CGRP). However, AS chemistry may involve generation of other NO-related species, i.e.
nitrates. To more specifically assess HNO/NO- signaling, we developed and tested a
novel organic compound isopropylamine/NO (IPA/NO), a near pure (>95%) HNO/NO-
donor.
Methods: Pressure-volume relations were assessed in conscious dogs under basal con-
ditions and after induction of heart failure (HF) by tachypacing.
Results: IPA/NO (5µg/kg/min) increased contractility (end-systolic elastance, Ees,) by
58.0±8.1% (p<0.001) in control and 46.8±10.2% (p<0.01) in HF, and lowered preload and
afterload similarly in healthy and CHF dogs. This contrasted to negative inotropic effects
from equidilative doses of diethylamine/NO (DEA/NO, pure NO donor, 2µg/kg/min), S-
Nitrosoglutathione (GSNO, pure NO doror, 0.625µg/kg/min) or nitroglycerin (NTG, 10µg/
kg/min). Isovolumic relaxation was 6.1±3.8% faster with IPA/NO in control hearts, and
this effect was more pronounced in HF (28.3±6.4%; p<0.05 vs. control hearts). Co-infu-
sion of dobutamine with IPA/NO further augmented contractility by 46.0±16% (p<0.05) in
control and 31.4+/-6.5% (p<0.05) in HF above dobutamine alone, whereas DEA/NO,
GSNO or NTG blunted β-stimulation. IPA/NO inotropic/lusitropic action was unaffected by
β-blockade (timolol, 2mg/kg). IPA/NO increased arterial plasma CGRP (30.3±6.0 to
65.1±2.8 pg/ml; p<0.005) and neurotensin (78.6±7.3 to 170.0±25.3pg/ml; p<0.01),
reflecting NANC stimulation. Responses to IPA/NO were very similar to those previously
reported from AS.
Conclusion: The novel HNO/NO- donor, IPA/NO, has potent inotropic and lusitropic
effects in failing hearts that are synergistic with β-agonist stimulation. Unlike inorganic
AS, this new organic compound has potential for clinical development as an NO-related
species with both vasoactive and cardiotropic effects, for use in the treatment of heart
failure.
1144-127 Effects of Inotropic Stimulation on Left Ventricular 
Torsional Deformation in Tachycardia-Induced Dilated 
Cardiomyopathy
Filiberto Rodriguez, Katherine B. Harrington, Frederick A. Tibayan, Paul Dagum, Frank 
Langer, George T. Daughters, Neil B. Ingels, Jr., D. Craig Miller, Stanford University, 
Stanford, CA, Palo Alto Medical Foundation, Palo Alto, CA
Introduction: Tachycardia-induced cardiomyopathy (TIC) is accompanied by decreased
and delayed systolic left ventricular (LV) torsion and loss of early diastolic recoil, which
may contribute to LV dysfunction by increasing systolic transmural strain gradients and
impairing diastolic filling. To gain more mechanistic understanding of the pathophysiology
of this model of congestive heart failure (CHF), we examined the effects of inotropic stim-
ulation on torsional deformation at baseline and after the development of TIC.
Methods: Seven sheep had radiopaque markers implanted in the LV subepicardium to
measure: 1.) maximal systolic torsion (Φmax); and, 2.) diastolic torsion recoil during the
first 5% of filling (Φ5%) using biplane videofluoroscopy (60 Hz) one week after surgery,
before and during inotropic stimulation with dobutamine. Rapid ventricular pacing was
then implemented for 15±6 days to create TIC, and data were again acquired before and
during dobutamine infusion.
Results: Maximal torsion and recoil rate were restored to near-normal levels in TIC with
dobutamine (Table).
Conclusions: Inotropic stimulation with dobutamine may benefit patients with CHF, in
part, by restoring LV torsion dynamics, which may decrease systolic transmural strain
gradients and augment early-diastolic filling.
QoL
unadjusted 
scores
(mean±SD)
Anemia
(n)
Hgb Group (g/dl)
(n)
Yes
(257)
No
(523)
P* <12
(191)
12-12.9
(158)
13-13.9
(156)
>14
(275)
P†
KCCQ 
Functional 
Status
55 ± 22 60 ± 22 0.006 54 ± 22 56 ± 22 58 ± 22 64 ± 21 <0.001
Symptoms 58 ± 24 63 ± 24 0.006 56 ± 24 59 ± 24 62 ± 23 66 ± 24 <0.001
Clinical 56 ± 21 59 ± 21 0.022 54 ± 21 56 ± 20 58 ± 22 62 ± 20 <0.001
MLHF
Physical 19 ± 11 18 ± 12 0.041 20 ± 11 19 ± 11 18 ± 12 16 ± 11 0.003
Emotional 10 ± 
7.7
9.3 ± 
7.7
0.222 10 ± 
7.8
10 ± 
8.0
9.7 ± 
8.0
8.8 ± 
7.3
0.227
Summary 44 ± 26 41 ± 26 0.154 45 ± 26 44 ± 26 43 ± 27 39 ± 26 0.061
*P value from t-test, †P value from ANOVA. Both analyses based on unadjusted QoL 
scores.
preTIC TIC
HEMODYNAMICS preDobutami
ne
Dobutami
ne
preDobutami
ne
Dobutami
ne
Heart Rate (min-1) 115±19 146±14* 125±14 171±38*
dP/dtmax (mmHg/s) 1,850±458 3,170±828
*
1,530±468† 2,420±506
*
LVPmax (mmHg) 110±11 129±15* 115±13 127±17*
LVEDP (mmHg) 17±8 18±11 38±7† 42±11
LVESP (mmHg) 88±12 95±10 93±14 100±19
LVEDV (mL) 178±17 163±13* 226±19† 224±21
LVESV (mL) 139±15 123±8 189±21† 185±28
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1144-128 Calmodulin Kinase Activity Links Green Fluorescent 
Protein Overexpression to a Cardiomyopathic 
Phenotype
Michelle S. Khoo, Rong Zhang, Chad E. Grueter, Gemin Ni, Martha A. Bass, Corrie 
Painter, Mesut Eren, Jinying Yang, Ernest C. Madu, Lisa A. Mendes, Douglas E. 
Vaughan, Roger J. Colbran, Mark E. Anderson, Vanderbilt University Medical Center, 
Nashville, TN
Background: Transgenic (TG) expression of green fluorescent protein (GFP) causes
dilated cardiomyopathy in mice by unknown mechanisms. Calmodulin kinase (CaMK)
activity and expression are increased in cardiomyopathy.
Methods: We developed TG mice with cardiac expression of GFP fused to a CaMK-spe-
cific inhibitory peptide (IP) or a scrambled inactive control peptide (CP) to test if CaMK
activity determined cardiomyopathic responses to GFP.
Results: Cardiac dysfunction followed increased GFP expression and CaMK activity in
the GFP-CP TG mice (Table; *P < 0.05). In contrast, GFP-IP TG mice with significantly
higher GFP expression were protected from developing severe cardiomyopathy com-
pared to GFP-CP TG mice. CaMK inhibition in GFP-IP TG mice disrupted the relation-
ship between GFP expression and cardiac dysfunction seen in GFP-CP TG mice. Atrial
natriuretic peptide (ANP) expression is a marker of cardiac dysfunction. ANP increased
with GFP expression in GFP-CP TG mice, suggesting that GFP over-expression acti-
vated a CaMK signaling pathway linked to cardiomyopathy. GFP IP mice had lower ANP
message levels than GFP-CP TG mice, showing that reduced CaMK activity translated
into reduced activity of this CaMK-dependent cardiomyopathic signaling pathway.
Conclusion: These findings implicate CaMK as a specific signal activated in GFP TG
cardiomyopathy and suggest the hypothesis that other types of cardiomyopathy with
abnormal protein expression may also be linked to increased CaMK activity.
1144-129 Optimal Preload Adjustment of Right Ventricular Power 
Allows for Single Beat Estimation of Contractility
Soren Schenk, Zoran B. Popovic, Patrick M. McCarthy, Yoshie Ochiai, Randall C. 
Starling, Jose L. Navia, Yoshio Ootaki, Keiji Kamohara, James D. Thomas, Kiyotaka 
Fukamachi, Cleveland Clinic Foundation, Cleveland, OH
Background Right ventricular (RV) maximal power (PWRmax) is closely related to RV
stroke work, and is a sensitive, yet, preload dependent parameter of contractility.We
hypothesized that the relationship of PWR vs end–diastolic volume (EDV), analogous to
RV stroke work vs EDV relationship (PRSW), may be linearly modeled with x-axis inter-
cept (V0PWR) corresponding to PRSW intercept (V0PRSW).
Methods Nine dogs were instrumented with pulmonary flow probe, RV micromanometer,
and conductance catheter. RV volume signals were calibrated by flow probe and
echocardiography. Data were obtained during bicaval occlusions (n=78) under various
hemodynamic conditions (baseline, atrial pacing at 90, 120, and 150 bpm, and dob-
utamine infusion) and fitted to the equation PWR = a·(EDV- V0PWR)b.
Results The PWR vs EDV relationship did not deviate from linearity (b=1.1 ± 0.6, p = NS
vs 1.0), and V0PWR correlated closely with V0PRSW (r = 0.93, p<0.0001). V0PRSW was
related to steady state EDV by equation V0PRSW =0.63·EDV-6.5 (r=0.833, p<0.0001),
allowing for single beat estimation of V0PWR (V0EST) and for preload adjustment of PWR-
max. Dividing PWRmax by the difference of EDV and V0PWR (PAMPV0-PWR) eliminated
preload dependency (± 3.0%) down to 50% of baseline EDV. Preload independency of
PAMPV0-PWR was confirmed by numerical modeling of actual data testing various
V0PWR, EDV, PRSW, and PWR. Similarly, PWRmax adjustment using V0EST (PAMPV0-
EST) showed preload independency down to 75% of baseline EDV. Enhancing contractil-
ity by dobutamine increased PAMPV0-PWR and PAMPV0-ES from 173 ± 87 to 417 ± 225
W/ml·104 and 178 ± 48 to 464 ± 284 W/ml·104, respectively (both p=0.01), accompanied
by increase of PRSW from 13.6 ± 4.3 to 30.1 ± 17.4 mm Hg (p<0.05). Both PAMPV0-PWR
and PAMPV0-EST correlated closely with PRSW (r=0.86, p<0.001; r=0.93, p<0.001).
Conclusion Optimal preload adjustment of RV PWRmax can be achieved by considering
linear PWR vs EDV relationship and V0PWR presence. Adjusting PWRmax by steady
state EDV and V0EST (PAMPV0-EST) may be a useful, preload independent estimate of
RV contractility that can potentially be determined non–invasively without the need for
bicaval occlusion.
1144-130 Calpain Activation and Inhibition in Acute Right Heart 
Failure
Hasan A. Ahmad, Li Lu, Ya Xu, Jennifer Fox, Gregory G. Schwartz, Clifford R. Greyson, 
Veterans Affairs Medical Center, Denver, CO, University of Colorado Health Sciences 
Center, Denver, CO
Right ventricular (RV) failure from acute pressure overload (RVPO) is an important cause
of morbidity and mortality in patients. We previously showed that RV contractile dysfunc-
tion develops during experimental RVPO in pigs in the absence of RV ischemia, and per-
sists after normal loading conditions are restored. We hypothesized that RV dysfunction
from RVPO is due in part to activation of the calcium sensitive protease calpain, and that
calpain inhibition would attenuate RV dysfunction during RVPO.
Methods: Anesthetized open chest pigs were randomized to treatment with a calpain
inhibitor (MDL-28170, INH) or inactive vehicle (VEH) infused into the right coronary
artery, then subjected to RVPO by a constant degree of pulmonary artery constriction for
4 hrs. Contractile function was assessed by RV stroke work. In a second series of exper-
iments, calpain activation after RVPO was assessed by Western blotting of spectrin
breakdown products.
Results: At the beginning of RVPO, RV systolic pressure was 60±5 mmHg in both
groups. Compared with VEH pigs, INH pigs maintained significantly higher RV stroke
work during 4 hrs RVPO (Figure Left). RV myocardium from INH pigs showed less
calpain activation after RVPO than VEH pigs (Figure Right). Four VEH pigs, but no INH
pigs, failed to complete the protocol due to RV failure and hypotension and were not
included in this analysis.Conclusions: RV dysfunction during RVPO is attenuated by
calpain inhibition, offering a potential new therapeutic strategy in this condition. 
1144-131 AKT Signaling in Pacing-Induced Heart Failure
Radha Ananthakrishna, Michael J. Goldenthal, Gordon W. Moe, Jose Marin-Garcia, The 
Molecular Cardiology and Neuromuscular Institute, Highland Park, NJ
Background: Marked changes in energy substrate utilization occur during the progres-
sion of congestive heart failure (CHF) where free fatty acid utilization, as the primary
souce of cardiac energy is severely diminished, oxidative phosphorylation is down-regu-
lated and glucose uptake and utilization increase. While the molecular basis for the shift
in substrate utilization has not yet been elucidated, we sought to examine in the canine
model of paced-induced heart failure the potential role of the AKT pathway (previously
implicated in the events of cardiac hypertrophy) in signaling the metabolic transition of
CHF.
Methods: Left ventricular samples from early (1-2 weeks) and late (3-4 weeks) stages of
pacing-induced CHF animals (n=6 and 6 respectively) were evaluated for the levels of
both phosphorylated and non-phosphorylated AKT, as well as for AKT kinase activity and
were compared to control unpaced animals (n=6). In addition, markers of cardiac hyper-
trophy(e.g. actin, ANP, BNP, beta-MHC and SERCA 2) were assessed by immunoblot
analysis as were myocardial levels of free fatty acids and glucose.
Results: Significant increases in the phosphorylated AKT form (1.7 fold) and in AKT
kinase activity (3 fold) were found in early paced animals; these levels declined in the late
stages of pacing. Significant increases were also found in the myocardial free fatty acid
content (mean 1.0 +/- 0.27 vs. controls 0.41+/- 0.13) and only a mild decrease in glucose
level (10%) in late but not in early pacing. Markers of cardiac hypertrophy showed no dif-
ferences in the paced animals compared to control.
Conclusion: Our data demonstrate that AKT signaling pathway is a contributory element
in the early signaling events leading to the progression of pacing-induced heart failure,
accompanying the shift in substrate utilization and, contrary to the transgenic mice
model, is independent of cardiac hypertrophy. The decline in AKT phoshorylation and
kinase activation in the later stages of the pacing-induced events is also consistent with
the observed onset of myocardial apoptosis previously described in the pacing model, a
process known to be reversed by AKT pathway activation.
TORSION DYNAMICS
_max (degrees) 3.9±3.3 5.9±2.0* 0.5±1.0† 2.1±0.8*
Recoil (_5%) (degrees) -1.6±1.6 -2.0±1.6 -0.4±1.5 -1.1±1.0
Recoil Rate (d_5%/dt) 
(degrees/ms)
0.03±0.03 0.05±0.04* -0.001±0.02† 0.03±0.02*
* p < 0.05, preDobutamine vs. Dobutamine, 2-way RM ANOVA with SNK post-test.
† p < 0.05, preTIC vs. TIC, 2-way RM ANOVA with SNK post-test.
Data expressed as Mean±1SD.
TG (Line) [GFP] ng/µl CaMK Activity 
(nmol/mg/min)
Left Ventricular Fractional 
Shortening (%)
IP (L1) 
(n = 10)
89.6 ± 4.8 2.4 ± 0.2 58.9 ± 1.9
IP (L2) 
(n = 9)
125.7 ± 13.7* 3.2 ± 0.2* 46.2 ± 5.7*
CP (L1) 
(n = 10)
85.1 ± 5.9 4.3 ± 0.3* 27.7 ± 2.9*
CP (L2) 
(n = 10)
52.9 ± 1.6* 3.4 ± 0.3 54.7 ± 1.7
